BridgeBio Pharma, Inc. (BBIO)
NASDAQ·Healthcare·Biotechnology
$83.50
-2.40%
Mkt Cap $16.46B
Analyst Ratings
Buy
19
Hold
1
Sell
0
Price Target (44 analysts)
$104.60
Range $83.00 – $157.00
Implied Upside
+25.3%
Consensus $104.60 vs current $83.50
NASDAQ·Healthcare·Biotechnology
$83.50
-2.40%
Mkt Cap $16.46B
Buy
19
Hold
1
Sell
0
Price Target (44 analysts)
$104.60
Range $83.00 – $157.00
+25.3%
Consensus $104.60 vs current $83.50